Press Release
DCAT 2011-2012 Board of Directors To Take Office November 1
Robbinsville, NJ, October 31, 2011 – DCAT is pleased to announce that the slate of candidates for the 2011-2012 Board of Directors was approved by member company designated contacts.
Joan Connolly, principal of Connovan Consulting, will serve as president, taking office on November 1, along with the other elected board members.
Former DCAT President
Bob Kanuga, vice president of external manufacturing at Merck & Co., Inc. will join the Executive Committee’s Advisory Council.
Joining the Executive Committee are
George Svokos, executive vice president, commercial operations, Teva API, Inc. as vice president;
Folker Ruchatz, vice president, global business management custom synthesis, BASF as segment vice president—chemical industry; and
Rosina Vega, co-owner, GreenField Chemical, Inc. as segment vice president—pharmaceutical services industry.
Completing their two-year-term on the Executive Committee are
Don E. LaFerle, president, sales & marketing, IRIX Pharmaceuticals, Inc. and
Dave McCleary, president, CUSTOpharm, Inc.
Completing their three-year-term on the Board of Directors are
Dennis Bauer, vice president, commercial and business development at Johnson Matthey Pharmaceutical Materials & Services;
Thomas Miller, former director, strategic sourcing at Bristol-Myers Squibb Worldwide Medicines Group;
Larry Walsh, global sales manager—health & nutrition at Huber Engineered Materials—Health & Nutrition, and
Michael van Winden, formerly of EMD Chemicals Inc.
Completing his term on the DCAT Advisory Council is
Dix Weaver, advisor, Evonik Degussa Corporation. Mr. Weaver served as the association's president in 2007-2008.
Also joining the board are
Milton Boyer, vice president, business development at Oso BioPharmaceuticals Manufacturing, LLC;
Jai Hiremath, vice chairman & managing director, Hikal Ltd.;
Paolo Magri, director business development, marketing & sales, Infa, Inc.;
Tim McCarthy, senior manager business development API, Piramal Healthcare;
Deborah Poenisch, vice president business development, VWR International, LLC; and
Scott Zook, senior director, chemical development, Neurocrine Biosciences.
Below is the full slate of the newly elected Board of Directors:
Officers of the Executive Committee of the Board of Directors (1 Year Term):
President:
Joan Connolly, Principal, Connovan Consulting
Sr. Vice President:
J. Tyson Popp, Vice President, Research & Development, West Pharmaceutical Services, Inc.
Finance Officer:
Lyra Myers, Senior Procurement Manager, Chemicals, Genentech, Inc.
Vice President:
George Svokos, Executive Vice President, Commercial Operations, Teva API, Inc.
Vice Presidents of the Executive Committee of the Board of Directors (1 Year Term):
Biotechnology Industry Segment Vice President:
David Cady, Director, Global Strategic Sourcing, Amgen Inc.
Chemical Industry Segment Vice President:
Folker Ruchatz, Vice President, Global Business Management Custom Synthesis,
BASF
Contract Formulation, Fill, Finish & Packaging Industry Segment Vice President:
Pam Tyler, Senior Purchasing Manager, DPT Laboratories, Ltd.
Pharmaceutical Industry Segment Vice President:
Ron Perry, Senior Director, Global Leader, Global Procurement & Operations, Pfizer Inc.
Pharmaceutical Services Industry Segment Vice President:
Rosina Vega, Co-Owner, GreenField Chemical, Inc.
Board of Directors (3 Year Term):
Milton Boyer, Vice President, Business Development, OSO BioPharmaceuticals
Manufacturing, LLC
Jai Hiremath, Vice Chairman & Managing Director, Hikal Ltd.
Paolo Magri, Director Business Development, Marketing & Sales, Infa, Inc.
Timothy McCarthy, Senior Manager Business Development API, Piramal Healthcare
Deborah Poenisch, Vice President Business Development, VWR International, LLC
Scott Zook, Senior Director, Chemical Development, Neurocrine Biosciences
About DCAT
DCAT is the premier business development association whose membership is comprised of companies that manufacture, distribute or provide services to the pharmaceutical, chemical and related industries.
Contact:
Erin Sanders
DCAT Communications Coordinator
609-448-1000